Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.75 EUR | +3.71% | +12.83% | -11.38% |
May. 15 | BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction | |
May. 15 | Bastide: 8.2% increase in quarterly sales | CF |
Sales 2024 * | 529M 574M | Sales 2025 * | 560M 607M | Capitalization | 176M 191M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.35M | Net income 2025 * | 22M 23.86M | EV / Sales 2024 * | 0.96 x |
Net Debt 2024 * | 333M 362M | Net Debt 2025 * | 328M 355M | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
10.4
x | P/E ratio 2025 * |
7.69
x | Employees | 3,635 |
Yield 2024 * |
1.98% | Yield 2025 * |
2.42% | Free-Float | 44.92% |
1 day | +3.71% | ||
1 week | +12.83% | ||
Current month | +31.94% | ||
1 month | +42.39% | ||
3 months | +23.31% | ||
6 months | -3.06% | ||
Current year | -11.38% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 23.75 | +3.71% | 14,803 |
24-05-23 | 22.9 | +3.62% | 16,835 |
24-05-22 | 22.1 | +2.79% | 6,293 |
24-05-21 | 21.5 | +1.65% | 5,737 |
24-05-20 | 21.15 | +0.48% | 5,528 |
Real-time Euronext Paris, May 24, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.38% | 191M | |
+1.23% | 3.14B | |
0.00% | 1.94B | |
+20.20% | 1.8B | |
+68.75% | 706M | |
-14.59% | 443M | |
-17.65% | 129M | |
+3.85% | 69.12M |
- Stock Market
- Equities
- BLC Stock